Tofajoint 5mg Tablet

Tofajoint 5mg Tablet contains tofacitinib, a disease-modifying antirheumatoid agent (DMARD) belonging to the class of immunomodulators. It is used alone or in combination with other medicines to treat rheumatoid arthritis (a condition in which the body's immune system attacks the joints, causing pain, swelling, and reduced function) in adults who cannot tolerate or do not respond to other treatment options. It is also used to treat psoriatic arthritis (a condition characterised by joint pain, swelling, and skin scaling). Tofajoint 5mg Tablet is indicated for treating adult patients with moderately to severely active ulcerative colitis. Additional uses include ankylosing spondylitis (an inflammatory disease of the spine) and active polyarticular juvenile idiopathic arthritis, a chronic disease causing pain and swelling of the joints in patients aged 2 years and above. The medicine works by reducing the activity of the immune system. Inform your doctor if you have severe blood infection, active tuberculosis, or liver problems. Notify your doctor if you have ever had or currently have hepatitis B infection, as this medicine may reactivate hepatitis B. Do not use Tofajoint 5mg Tablet if you are allergic to tofacitinib or any other ingredient in this medicine. Inform your healthcare professional if you experience any signs of infection, including fever, sweating, chills, muscle aches, cough, shortness of breath, weight loss, skin sores, difficulty or pain on swallowing, diarrhoea, or stomach pain. Before starting treatment, inform your doctor if you have kidney, heart, lung, or liver disease, a history of tuberculosis, high blood pressure, high cholesterol, or if you are a current or former smoker.

Tofajoint 5mg Tablet is used in the treatment of the following: Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Ulcerative colitis Polyarticular juvenile idiopathic arthritis Juvenile psoriatic arthritis

Tofajoint 5mg Tablet is a disease-modifying anti-rheumatic drug (DMARD) that belongs to the category of Janus Kinase Inhibitors. Janus kinase is a type of enzyme (tyrosine kinase) involved in the signalling of cytokine receptors. Tofajoint 5mg Tablet works by inhibiting Janus kinases and interferes with the transcription of genes involved in cell growth and differentiation.

Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take the tablet with or without food.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of Tofajoint 5mg Tablet are: Increased cholesterol levels Headache Painful urination Inflammation of the nose Cough Shortness of breath Diarrhea Skin rashes Serious side effects of Tofajoint 5mg Tablet are: Lung cancer White blood cell cancer Heart attack Fever and chills Blood in the stool Stomach pain or abdominal pain Skin blisters

This medicine may interfere with vaccines. Inform your physician about all your vaccination history. This medicine may impair fertility; talk to your doctor before taking this medicine. Your doctor will regularly do lab tests to check whether the medicine is working. Do not breastfeed during the treatment with this medicine and for at least 36 hours after your last dose. This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury.